[Controversies in the management of type 2 diabetes].
The new national guideline for the management of type 2 diabetes recommends procedures for the diagnosis and treatment of the metabolic disease. However, the contributing medical associations could not agree on some questions. Above all, there is a dissent which drug to choose, if metformin cannot be used or does not suffice in monotherapy.